Hillhouse Capital Advisors, Ltd.
13F Reported Value
ⓘ$1.7B
Holdings
38
Latest Filing
2026-03-31
Filing Quarter
Q1 2026
Portfolio Overview
Hillhouse Capital Advisors, Ltd. disclosed 38 positions worth $1.7B in its Form 13F-HR for Q1 2026, led by $PDD (PDD Holdings Inc.) at 25.4% of the equity portfolio, followed by $BABA and $ONC. During the quarter the fund opened 9 new positions and exited 3 — including a new stake in $MRVL and a full exit from $GOOG. The portfolio is most concentrated in Industrials (44.0% of disclosed assets). All figures are sourced directly from Hillhouse Capital Advisors, Ltd.’s Form 13F-HR filing with the SEC under CIK 1762304.
AI Fund Analysis
DiversifyingSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q1 2026
Click any card to unlockTop Holdings
- —
Quality
$425.6M4,165,029 sh - —
Quality
$307.8M2,453,657 sh - —
Quality
$307.2M1,034,306 sh - —
Quality
$194.1M1,419,483 sh - 44.2
Quality
$108.3M5,984,550 sh - —
Quality
$90.6M3,929,117 sh - —
Quality
$63.4M4,236,278 sh - 50.2
Quality
$32.3M1,365,971 sh - 25.8
Quality
$29.1M6,657,030 sh - 77.3
Quality
$16.9M171,033 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 PDD Holdings Inc.$PDD | — | $425.6M | 4,165,029 |
 Alibaba Group Holding Ltd$BABA | — | $307.8M | 2,453,657 |
 BeOne Medicines Ltd.$ONC | — | $307.2M | 1,034,306 |
 Futu Holdings Ltd$FUTU | — | $194.1M | 1,419,483 |
 Legend Biotech Corp$LEGN | 44.2 | $108.3M | 5,984,550 |
 ArriVent BioPharma, Inc.$AVBP | — | $90.6M | 3,929,117 |
 KE Holdings Inc.$BEKE | — | $63.4M | 4,236,278 |
 Clearwater Analytics Holdings, Inc.$CWAN | 50.2 | $32.3M | 1,365,971 |
 Cytek Biosciences, Inc.$CTKB | 25.8 | $29.1M | 6,657,030 |
 Marvell Technology, Inc.$MRVL | 77.3 | $16.9M | 171,033 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Hillhouse Capital Advisors, Ltd.'s 38 positions.
Showing top 10 of 38 holdings.
Sector Allocation
Industrials
$735.4M
Healthcare
$546.4M
Financials
$201.3M
Technology
$103.7M
Real Estate
$63.4M
Consumer Staples
$15.0M
Materials
$3.2M
Consumer Discretionary
$2.9M
Full Holdings — Hillhouse Capital Advisors, Ltd. (Q1 2026)
All 38 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $PDD | PDD Holdings Inc. | $425.6M | 25.4% | -61% | — |
| 2 | $BABA | Alibaba Group Holding Ltd | $307.8M | 18.4% | -55% | — |
| 3 | $ONC | BeOne Medicines Ltd. | $307.2M | 18.4% | +0% | — |
| 4 | $FUTU | Futu Holdings Ltd | $194.1M | 11.6% | -13% | — |
| 5 | $LEGN | Legend Biotech Corp | $108.3M | 6.5% | +0% | 44.2 |
| 6 | $AVBP | ArriVent BioPharma, Inc. | $90.6M | 5.4% | +0% | — |
| 7 | $BEKE | KE Holdings Inc. | $63.4M | 3.8% | +0% | — |
| 8 | $CWAN | Clearwater Analytics Holdings, Inc. | $32.3M | 1.9% | +0% | 50.2 |
| 9 | $CTKB | Cytek Biosciences, Inc. | $29.1M | 1.7% | +0% | 25.8 |
| 10 | $MRVL | Marvell Technology, Inc. | $16.9M | 1.0% | NEW | 77.3 |
| 11 |  $YSG | Yatsen Holding Ltd | $15.0M | 0.9% | +0% | — |
| 12 |  $NBP | NovaBridge Biosciences | $14.7M | 0.9% | +0% | — |
| 13 |  $MAZE | Maze Therapeutics, Inc. | $10.9M | 0.7% | -20% | 19.7 |
| 14 |  $CTNM | Contineum Therapeutics, Inc. | $8.7M | 0.5% | +0% | — |
| 15 |  $API | Agora, Inc. | $7.4M | 0.4% | +0% | — |
| 16 |  $BULL | Webull Corp | $7.2M | 0.4% | -75% | — |
| 17 |  $TSM | TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD | $5.2M | 0.3% | +37% | — |
| 18 |  $SGMT | Sagimet Biosciences Inc. | $3.8M | 0.2% | +0% | — |
| 19 |  $TUYA | Tuya Inc. | $3.6M | 0.2% | +0% | — |
| 20 |  $GE | GENERAL ELECTRIC CO | $2.8M | 0.2% | +0% | 74.8 |
| 21 |  $VIPS | Vipshop Holdings Ltd | $2.0M | 0.1% | NEW | — |
| 22 |  $MOGU | MOGU Inc. | $1.9M | 0.1% | +0% | — |
| 23 |  $GOSS | Gossamer Bio, Inc. | $1.6M | 0.1% | +0% | 27.1 |
| 24 |  $INTC | INTEL CORP | $1.3M | 0.1% | NEW | 41.5 |
| 25 |  $PACB | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | $1.2M | 0.1% | +0% | 10.8 |
| 26 |  $EQX | Equinox Gold Corp. | $1.2M | 0.1% | +0% | — |
| 27 |  $NVDA | NVIDIA CORP | $1.2M | 0.1% | NEW | 90.2 |
| 28 |  $LITE | Lumentum Holdings Inc. | $1.1M | 0.1% | NEW | 63.4 |
| 29 |  $GLW | CORNING INC /NY | $1.0M | 0.1% | NEW | 72.7 |
| 30 |  $B | BARRICK MINING CORP | $1.0M | 0.1% | +0% | — |
| 31 |  $COHR | COHERENT CORP. | $1.0M | 0.1% | NEW | 64 |
| 32 |  $DDL | Dingdong (Cayman) Ltd | $911,065 | 0.1% | NEW | — |
| 33 |  $AXIA | AXIA Energia S.A. | $711,768 | 0.0% | -35% | — |
| 34 | — | ISHARES INC | $662,024 | 0.0% | NEW | — |
| 35 |  $ALGS | Aligos Therapeutics, Inc. | $566,515 | 0.0% | +0% | — |
| 36 |  $VNET | VNET Group, Inc. | $546,189 | 0.0% | +23% | — |
| 37 |  $UXIN | Uxin Ltd | $58,809 | 0.0% | +0% | — |
| 38 |  $RDGT | Ridgetech Inc. | $657 | 0.0% | +0% | — |
New Positions (9)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Hillhouse Capital Advisors, Ltd. including:
Track Hillhouse Capital Advisors, Ltd.'s Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Hillhouse Capital Advisors, Ltd. and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Hillhouse Capital Advisors, Ltd.
13F Pro is an AI hedge fund tracker and stock research platform. For Hillhouse Capital Advisors, Ltd. (SEC CIK: 1762304), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Hillhouse Capital Advisors, Ltd.'s portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.